Raising the bar for enthusiasm when looking at results of randomized phase II trials—the case of sunitinib in small-cell lung cancer

Por Di Maio, Massimo, Bironzo, Paolo, Scagliotti, Giorgio Vittorio
Publicado no Transl Lung Cancer Res (2016)

Statistical control process to compare and rank treatment plans in radiation oncology: impact of heterogeneity correction on treatment planning in lung cancer

Por Chaikh, Abdulhamid, Balosso, Jacques
Publicado no Transl Lung Cancer Res (2016)

Silencing of advanced glycosylation and glycosylation and product-specific receptor (RAGE) inhibits the metastasis and growth of non-small cell lung cancer

Por Yu, Yan Xia, Pan, Wen Chong, Cheng, Yu Feng
Publicado no Am J Transl Res (2017)

Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment

Por Nel, Ivonne, Jehn, Ulrich, Gauler, Thomas, Hoffmann, Andreas-Claudius
Publicado no Transl Lung Cancer Res (2014)

Up-regulation of long non-coding HOTTIP functions as an oncogene by regulating HOXA13 in non-small cell lung cancer

Por Sang, Yulan, Zhou, Fucheng, Wang, Dongjie, Bi, Xin, Liu, Xuanxi, Hao, Zhen, Li, Qingsong, Zhang, Wei
Publicado no Am J Transl Res (2016)

Tumor profiling of co-regulated receptor tyrosine kinase and chemoresistant genes reveal different targeting options for lung and gastroesophageal cancers

Por Wu, Jianzhong, Li, Shuchun, Ma, Rong, Sharma, Ashok, Bai, Shan, Dun, Boying, Cao, Haixia, Jing, Changwen, She, Jinxiong, Feng, Jifeng
Publicado no Am J Transl Res (2016)

MiR-182 promotes cell proliferation by suppressing FBXW7 and FBXW11 in non-small cell lung cancer

Por Chang, Hao, Liu, Yue-Hong, Wang, Li-Li, Wang, Ju, Zhao, Zhi-Hong, Qu, Jun-Feng, Wang, Sheng-Fa
Publicado no Am J Transl Res (2018)

Long noncoding RNA CASC15 predicts unfavorable prognosis and exerts oncogenic functions in non-small cell lung cancer

Por Li, Min, Chen, Yu, Zhu, Jicun, Gao, Zhan, Wang, Tao, Zhou, Pengli
Publicado no Am J Transl Res (2019)

Caspase-8 knockdown suppresses apoptosis, while induces autophagy and chemo-sensitivity in non-small cell lung cancer cells

Por Zuo, Hui, Chen, Cheng, Ma, Ling, Min, Qiu-Xia, Shen, Yue-Hai
Publicado no Am J Transl Res (2020)

LncRNA PVT1 overexpression is a poor prognostic biomarker and regulates migration and invasion in small cell lung cancer

Por Huang, Chengsuo, Liu, Shuguang, Wang, Huijun, Zhang, Zicheng, Yang, Qing, Gao, Fang
Publicado no Am J Transl Res (2016)

Methylation of kruppel-like factor 2 (KLF2) associates with its expression and non-small cell lung cancer progression

Por Jiang, Wenbin, Xu, Xueqing, Deng, Shaoli, Luo, Jie, Xu, Huan, Wang, Chao, Sun, Tingting, Lei, Guoqin, Zhang, Fengling, Yang, Cheng, Zhou, Lin, Wang, Feng, Chen, Ming
Publicado no Am J Transl Res (2017)

Shared decision-making conversations and smoking cessation interventions: critical components of low-dose CT lung cancer screening programs

Por Lowenstein, Lisa M., Deyter, Gary M. R., Nishi, Shawn, Wang, Tianhao, Volk, Robert J.
Publicado no Transl Lung Cancer Res (2018)

Exploring barriers to lung cancer patient access, diagnosis, referral and treatment in Kwazulu-Natal, South Africa: the health providers’ perspectives

Por Lubuzo, Buhle, Ginindza, Themba, Hlongwana, Khumbulani
Publicado no Transl Lung Cancer Res (2019)

BPTF cooperates with p50 NF-κB to promote COX-2 expression and tumor cell growth in lung cancer

Por Dai, Meng, Hu, Sheng, Liu, Chun-Fang, Jiang, Ling, Yu, Wendan, Li, Zheng-Lin, Guo, Wei, Tang, Ranran, Dong, Cheng-Yong, Wu, Tai-Hua, Deng, Wu-Guo
Publicado no Am J Transl Res (2019)

Perspective on treatment for unresectable locally advanced non-small cell lung cancer with oncogene-driven mutation: a narrative review

Por Jiang, Liyang, Meng, Xiangjiao, Zhao, Xianguang, Xing, Ligang, Yu, Jinming
Publicado no Transl Lung Cancer Res (2020)

Treatment of stage III non-small cell lung cancer in the era of immunotherapy: pathological complete response to neoadjuvant pembrolizumab and chemotherapy

Por Yang, Zhang-Ru, Liu, Mi-Na, Yu, Jia-Hua, Yang, Yun-Hai, Chen, Tian-Xiang, Han, Yu-Chen, Zhu, Lei, Zhao, Ji-Kai, Fu, Xiao-Long, Cai, Xu-Wei
Publicado no Transl Lung Cancer Res (2020)

Concurrent chemoradiotherapy for stage III non-small-cell lung cancer: recent progress and future perspectives (a narrative review)

Por Łazar-Poniatowska, Małgorzata, Bandura, Artur, Dziadziuszko, Rafał, Jassem, Jacek
Publicado no Transl Lung Cancer Res (2021)

P22. The serum levels, phenotypes and expression of alpha-1-antitrypsin in non-small cell lung cancer—pilot study

Por Szpechcinski, Adam, Langfort, Renata, Poplawska-Wisniewska, Beata, Giedronowicz, Dorota, Kupis, Wlodzimierz, Rudzinski, Piotr, Zaleska, Jolanta, Orlowski, Tadeusz, Roszkowski-Sliz, Kazimierz, Chorostowska-Wynimko, Joanna
Publicado no Transl Lung Cancer Res (2014)

Prognostic value of circulating endothelial cells in non-small cell lung cancer patients: a systematic review and meta-analysis

Por Liu, Yafang, Yuan, Dongmei, Ye, Wei, Lv, Tangfeng, Song, Yong
Publicado no Transl Lung Cancer Res (2015)

Does selected immunological panel possess the value of predicting the prognosis of early-stage resectable non-small cell lung cancer?

Por Zhang, Xiaoshen, He, Yayi, Jia, Keyi, Dziadziuszko, Rafal, Zhao, Sha, Deng, Juan, Wang, Hao, Hirsch, Fred R., Zhou, Caicun
Publicado no Transl Lung Cancer Res (2019)